Fibrinogenolysis and prolonged blood coagulation have been observed following large intravenous doses of crystalline trypsin ( 1 ) .2 The present study was undertaken to evaluate further the effects of intravenous crystalline trypsin upon the protein components of the coagulation mechanism and the fibrin content of artificially induced intravascular thrombi, in 60 rabbits and 25 dogs. A striking observation in this study was the lack of untoward reactions, including shock, when the rate and concentration of injected trypsin were kept within carefully calculated limits. MATERIALS 1) Sixty rabbits whose average weight was 2 kg. were fed rabbit food pellets and given water ad libitum.
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2) Twenty-five mongrel dogs, including 5 dogs used as controls, were housed together and fed Purina Dog Chow. Their average weight was between 10 to 12 kg.
3) Crystalline trypsin, i.e. Armour Tryptar@ preparation,8 was used in each experiment. 4) 0.5 ml. of 10 per cent sodium morrhuate, or 0.2 ml. (125 units) of topical thrombin (Parke, Davis), or 0.5 ml. of thromboplastin (simplastin) were used to produce thrombi in rabbits and dogs. 5) Bovine fibrinogen (Armour), and topical thrombin (Parke, Davis) were used in antithrombin determinations. METHODS 
1) Experimental production of thrombi in rabbits and
dogs. Experimental thrombi were produced in one of the marginal ear veins of each of 60 rabbits by injecting 0.5 ml. of 10 of trypsin to 6 dogs, no significant changes were noted in the coagulation mechanism (Table I) . Control studies included determinations of coagulation time, prothrombin time, factor V, antithrombin clotting time, and fibrinogen. Following the administration of trypsin intravenously in graded doses ranging from 500 to 5,000 units, no appreciable deviation from normal was noted.
Following the administration of intravenous trypsin in doses of 25,000 to 250,000 units in rabbits, and 50,000 to 1,000,000 units in dogs, the blood 1 -
No fibrinolysis. X Fibrinolysis within the first 24 hours. XX Fibrinolysis within 20 minutes.
coagulation time was prolonged, protein constituents of the clotting mechanism showed diminishing titers, the blood volume was reduced, and changes in the consistency and microscopic appearance of intravascular thrombi were observed. Quantitatively, these changes roughly paralleled the level of enzyme concentration infused at any given time.
A. Rabbits 1) Prothrombin. The magnitude of change in prothrombin time varied from 5 seconds in the control animals to greater than 100 seconds after the administration of more than 200,000 units of trypsin.
2) Factor V. plasmin by culture filtrates of Streptococci hemolyticus (streptokinase) (10), (b) the removal of plasmin inhibitor by certain organic solvents, such as chloroform and ether ( 11 ), (c) the activation of proplasmin into plasmin by a "Factor" from mammalian tissue (12), (d) the conversion of an inactive precursor enzyme present in culture filtrates of group A streptococci into a proteinase by autocatalysis or by the action of trypsin (13), (e) the action of pancreatic trypsin upon plasminogen causing the release of plasmin (14, 14a) and (f) the action of trypsin upon fibrin (15) .
Although there is convincing evidence that trypsin produces fibrinolysis in vitro, our observations on the fibrinolytic effects of intravenous trypsin do not necessarily prove a direct trypsinfibrin substrate interaction. Trypsin may resemble streptokinase in its capacity to activate a fibrinolytic system by transforming naturally occurring plasminogen into plasmin (14, 14a) . Whether plasmin then acts synergistically with trypsin, or the fibrinolytic effects following intravenous trypsin are predominantly due to the liberation of plasmin requires further evaluation.
There have been reports that intravenous trypsin caused shock (16) , intravascular coagulation (17, 19) local necrosis (18) , sloughing of tissue (18) , and was generally "too toxic for intravenous use" (19) . Occasionally, shock did appear when doses exceeding 150,000 units of trypsin were given to rabbits, or greater than 750,000 units were given to dogs.
We could not confirm the observation that a small dose of intravenous trypsin hastens blood coagulation or predisposes toward intravascular thrombosis (19) . Following administration of trypsin in the same small dose range previously associated with intravascular clotting (100 to 200 units/kg.) (20) , the coagulation time, prothrombin time, factor V, antithrombin and fibrinogen values were normal (Table I) . It is conceivable that circulating antitryptic substances adequately inactivate small quantities of injected trypsin. In order to rule out the possibility that multiple thrombi followed small trypsin doses despite normal findings of the circulating constituents measured, seven rabbits and three dogs were sacrificed following small intravenous trypsin doses. After extensive dissection, no evidence of intravascular thrombosis was noted either grossly or microscopically.
Marked anticoagulant effects followed large intravenous doses of trypsin. When the dose of trypsin was steadily increased (continuous intravenous infusion) a point was reached beyond which all clotting proteins were proteolyzed (Tables II and III ). In such extreme instances the blood became incoagulable presumably because the protein constituents of the coagulation mechanism had been depolymerized to amino acids.
The lytic effect of intravenous trypsin upon experimentally produced thrombi was most impressive. Gross changes in the rabbit ear vein thrombi following intravenous trypsin included 1) diminution and in several instances disappearance of the thrombus in situ, 2) restoration of local circulation, and 3) restoration of vessel wall compressibility. The microscopic features of trypsin treated thrombi included 1) diminution of fibrin, 2) diminution of cellular and platelet masses, and 3) no untoward effect upon vessel walls. Fibrinolytic effects extended into the laminations and interstices of the thrombus.
Gross changes were not observed in control animals with artificially induced clots who were given intravenous saline. Furthermore, it was noted microscopically, in these saline-treated control animals, that there was a persistence of the dense fibrin meshwork, plus homogenous masses of platelets and cells.
It appears probable, therefore, that the intravenous route effectively provides surface contact between proteolytic enzymes and the fibrin meshwork in thrombi, and that lysis of artificially formed thrombi in rabbits and dogs was produced by virtue of fibrinolytic mechanisms activated by intravenous trypsin. On the basis of these experimental data, the enzymatic action of in vivo trypsin upon the coagulation mechanism, and its effect upon fibrin and clots in situ, merits further study and elucidation. SUMMARY 1. Under controlled conditions of infusion rate, enzyme concentration, and dosage, the intravenous administration of trypsin is safe and feasible in rabbits and dogs.
2. Small trypsin doses in vitro produce clots. The effects of small trypsin doses in vivo is apparently nullified by circulating antitryptic substances.
3. Large trypsin doses both in vitro and in vivo have powerful anticoagulant effects.
4. Intravenously administered trypsin induces lytic effects upon artificially formed intravascular thrombi in rabbits and dogs.
